X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
zotarolimus-eluting stent (107) 107
cardiac & cardiovascular systems (101) 101
index medicus (101) 101
humans (95) 95
sirolimus - analogs & derivatives (80) 80
male (79) 79
female (76) 76
drug-eluting stents (74) 74
treatment outcome (73) 73
middle aged (68) 68
aged (61) 61
sirolimus - administration & dosage (56) 56
percutaneous coronary intervention (55) 55
thrombosis (53) 53
time factors (44) 44
implantation (41) 41
prosthesis design (41) 41
stent (40) 40
cardiovascular (38) 38
cardiology and cardiovascular medicine (35) 35
drug-eluting stent (34) 34
cardiovascular agents - administration & dosage (32) 32
everolimus-eluting stent (31) 31
stents (31) 31
bare-metal stents (29) 29
risk factors (29) 29
coronary artery disease - therapy (28) 28
outcomes (28) 28
percutaneous coronary intervention - adverse effects (28) 28
percutaneous coronary intervention - instrumentation (28) 28
prospective studies (27) 27
coronary angiography (26) 26
follow-up (26) 26
follow-up studies (26) 26
restenosis (25) 25
artery-disease (22) 22
lesions (22) 22
everolimus (21) 21
optical coherence tomography (21) 21
intervention (20) 20
coronary artery disease (19) 19
stent thrombosis (19) 19
cardiology (18) 18
drug-eluting stents - adverse effects (18) 18
dual antiplatelet therapy (18) 18
metaanalysis (18) 18
myocardial infarction - etiology (18) 18
coronary restenosis - etiology (17) 17
coronary restenosis - prevention & control (17) 17
multicenter (17) 17
zotarolimus-eluting stents (17) 17
efficacy (16) 16
revascularization (16) 16
aged, 80 and over (15) 15
kaplan-meier estimate (15) 15
percutaneous coronary intervention - methods (15) 15
percutaneous coronary intervention - mortality (15) 15
resolute zotarolimus-eluting stent (15) 15
safety (15) 15
trial (15) 15
coronary artery disease - diagnostic imaging (14) 14
coronary artery disease - mortality (14) 14
coronary heart disease (14) 14
paclitaxel-eluting stent (14) 14
sirolimus-eluting stent (14) 14
coronary vessels - diagnostic imaging (13) 13
heart attacks (13) 13
myocardial infarction (13) 13
paclitaxel - administration & dosage (13) 13
xience v stents (13) 13
abridged index medicus (12) 12
angioplasty, balloon, coronary - adverse effects (12) 12
coronary thrombosis - etiology (12) 12
coronary vessels (12) 12
drug therapy (12) 12
internal medicine (12) 12
transluminal angioplasty (12) 12
angioplasty, balloon, coronary - instrumentation (11) 11
clinical outcomes (11) 11
clopidogrel (11) 11
coronary artery disease - diagnosis (11) 11
coronary vessels - pathology (11) 11
paclitaxel (11) 11
platelet aggregation inhibitors - therapeutic use (11) 11
registries (11) 11
risk assessment (11) 11
sirolimus - adverse effects (11) 11
sirolimus - therapeutic use (11) 11
angioplasty (10) 10
cardiovascular disease (10) 10
care and treatment (10) 10
clinical-outcomes (10) 10
elevation myocardial-infarction (10) 10
everolimus - administration & dosage (10) 10
everolimus-eluting stents (10) 10
intravascular ultrasound (10) 10
meta-analysis (10) 10
randomized controlled trials as topic (10) 10
ultrasonography, interventional (10) 10
bare-metal (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Circulation Journal, ISSN 1346-9843, 2013, Volume 77, Issue 2, pp. 363 - 371
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2010, Volume 56, Issue 10, pp. S1 - S42
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 8, pp. 805 - 815
Abstract Background The use of drug-eluting stents (DES) in patients at high risk of bleeding or thrombosis has not been prospectively studied; limited data... 
Cardiovascular | Internal Medicine | dual-antiplatelet therapy | high bleeding risk | high thrombotic risk | zotarolimus-eluting stent(s) | drug-eluting stent(s) | dualantiplatelet therapy | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | NEOINTIMAL COVERAGE | ANGIOPLASTY | IMPLANTATION | POLYMER | ACUTE MYOCARDIAL-INFARCTION | OUTCOMES | DURATION | Coronary Artery Disease - surgery | Humans | Immunosuppressive Agents - therapeutic use | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Coronary Restenosis - diagnosis | Coronary Angiography - methods | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Risk Assessment | Risk Factors | Coronary Restenosis - prevention & control | Treatment Outcome | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - diagnosis | Aged | Biocompatible Materials - therapeutic use | Percutaneous Coronary Intervention - adverse effects | Sects | Stent (Surgery) | Heart attacks | Drug therapy | Stents | Coronary vessels
Journal Article
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2013, Volume 6, Issue 4, pp. 325 - 333
Journal Article
Journal Article
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 11/2016, Volume 88, Issue 6, pp. E173 - E182
Journal Article
BMC Cardiovascular Disorders, ISSN 1471-2261, 03/2017, Volume 17, Issue 1, p. 84
Background: Two thousand fifteen has been a winning year for Drug Eluting Stents (DES). Increase in the number of patients with cardiovascular diseases treated... 
Definite stent thrombosis | Everolimus eluting stents | Percutaneous coronary intervention | Zotarolimus eluting stents | Drug eluting stents | Probable stent thrombosis | MULTICENTER | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | SAFETY | XIENCE V STENTS | Definite stent | thrombosis | RESOLUTE STENTS | CORONARY INTERVENTION | CLINICAL-OUTCOMES | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Humans | Risk Factors | Treatment Outcome | Everolimus - administration & dosage | Chi-Square Distribution | Prosthesis Design | Randomized Controlled Trials as Topic | Coronary Thrombosis - diagnostic imaging | Sirolimus - administration & dosage | Coronary Artery Disease - diagnostic imaging | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Time Factors | Coronary Thrombosis - prevention & control | Everolimus - adverse effects | Coronary Thrombosis - etiology | Cardiovascular Agents - adverse effects | Odds Ratio | Percutaneous Coronary Intervention - adverse effects | Sirolimus - adverse effects | Intervention | Heart attacks | Clinical trials | Cardiovascular disease | Drug delivery | Patients | Thrombosis | Clinical outcomes | Meta-analysis | Studies | Consortia | Coronary vessels | Implants | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Stents
Journal Article
JACC : cardiovascular interventions, ISSN 1936-8798, 2015, Volume 8, Issue 7, pp. 889 - 899
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2011, Volume 57, Issue 11, pp. 1264 - 1270
Journal Article